Metabolic biomarkers are crucial for the early diagnosis and prognosis of cancer. They can help in distinguishing between different types of tumors and predicting the response to specific treatments. For instance, elevated levels of certain metabolites like lactate or glutamine can indicate the presence of cancer and its aggressiveness. These biomarkers can be non-invasively measured in biofluids, making them valuable tools for clinical applications.
